Global Gallbladder Cancer Treatment Market, By Indication Type (Stage I, Stage II, Stage III and Stage IV), Treatment Type (Surgery, Radiation Therapy, Chemotherapy and Immunotherapy), Diagnosis (Physical Examination, Liver Function Test, Blood Test, CT Scan, Ultrasound, Percutaneous Transhepatic Cholangiography (PTC), Endoscopic Retrograde Cholangiopancreatography (ERC), Magnetic Resonance Imaging (MRI), Endoscopic ultrasound (EUS), Laparoscopy and Biopsy), Route of Administration (Oral and Injections), End Users (Hospitals, Gynaecology Clinics, Academic and Research Centers), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Gallbladder Cancer Treatment Market
The gallbladder cancer treatment market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 6.50% in the above-mentioned research forecast period. The increase in gall bladder diseases such as gall bladder polyps, chronic inflammation and cholelithiasis increases the risk of developing and growing cancer cells in the gallbladder which has driven the growth of the gallbladder cancer treatment market.
Gallbladder is an organ which is situated under the lungs and is small and pear-shaped organ. The overgrowth of cancer or malignant cells in the tissues of the gallbladder leads to gallbladder cancer. The type of cancer is rare and mainly affects the female population. Different symptoms of gallbladder cancer are pain (above stomach), jaundice, lumps in the abdomen and fever. The gallbladder cancer is very difficult to detect in the early stage as there is absence of signs and if signs are there, it represents the other illnesses. For the treatment of cancer, different methods such as chemotherapy, immunotherapy, surgery and many other methods are done according to the patient’s adaptability and stage of the cancer. Drugs which are used for the treatment are gemzar, platinol, 5-fluorouracil, xeloda, and eloxatin. Immunotherapy drugs used for the treatment of cancer are nivolumab (opdivo) and pembrolizumab (keytruda). According to American Cancer Society, only 1 out of 5 gallbladder cancers are detected at early stage.
In addition, some other factors that have driven the gallbladder cancer treatment market growth are increase in incidence as well as prevalence of gallbladder cancer. For instance, according to American Cancer Society's (ACS) publication, in 2020, the estimated deaths from gallbladder cancer were 11,980 adults (5,600 men and 6,380 women) in the United States. The survival rate of gallbladder cancer is 19% and the survival rate also depends on the stage of cancer. If the cancer is diagnosed and is not spread in other organs, then the survival rate for 5 years can be increased to 62%.
Rising healthcare expenditure and adoption of advanced and innovative diagnostic and treatment methods may also drive the gallbladder cancer treatment market growth. For instance, in May 2016, F. Hoffmann-La Roche Ltd. had launched the new immunotherapy drug, atezolizumab which has been approved for the patient having metastatic urothelial carcinoma which is one of the type of gallbladder cancer.
However, pain and complications arise during the treatment and side-effects associated with the chemotherapy may restraint the gallbladder cancer treatment market growth. Side-effects of chemotherapy are change in taste, constipation, skin problems, hair loss, decrease in RBCs and blood platelets count and many others. Women who are on the chemotherapy may have irregular periods and abnormal bleeding. The women are at the higher risk of gallbladder cancer, therefore for them, mensuration problem is one of the side-effects. Neoadjuvant therapy is given before the main treatment. The neoadjuvant therapy has been given for the treatment of gallbladder cancer in place of adjuvant therapy. The increase in resectability rate and overall survival which shows positive results can act as an opportunity for the gallbladder cancer treatment market growth. Complete surgical tumour resection is the only treatment for the gallbladder cancer but the resection is one of the challenging tasks due to presence of important structures such as porta hepatica and there are some chances that the cancer can invade to the hepatic region. The other challenging factor is unavailability of adjuvant radiation therapy in low-income and underdeveloped countries.
This gallbladder cancer treatment market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the gallbladder cancer treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Gallbladder Cancer Treatment Market Scope and Market Size
The gallbladder cancer treatment market is segmented on the basis of indication type, treatment type, diagnosis, route of administration and end users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of indication type, the gallbladder cancer treatment market is segmented into stage I, stage II, stage III and stage IV.
- On the basis of treatment type, the gallbladder cancer treatment market is segmented into surgery, radiation therapy, chemotherapy and immunotherapy. Surgery is further sub-segmented into cholecystectomy, radical gallbladder resection and palliative surgery. Chemotherapy is further segmented into monotherapy and combination therapy.
- On the basis of diagnosis, the gallbladder cancer treatment market is segmented into physical examination, liver function test, blood test, CT scan, ultrasound, percutaneous transhepatic cholangiography (PTC), endoscopic retrograde cholangiopancreatography (ERC), magnetic resonance imaging (MRI), endoscopic ultrasound (EUS), laparoscopy and biopsy.
- On the basis of route of administration, the gallbladder cancer treatment market is segmented into oral and injections.
- On the basis of end users, the gallbladder cancer treatment market is segmented to hospitals, gynaecology clinics, academic and research centers.
Global Gallbladder Cancer Treatment Market Country Level Analysis
Global gallbladder cancer treatment market is analysed and market size information is provided by country, indication type, treatment type, diagnosis, route of administration and end users as referenced above.
The countries covered in the gallbladder cancer treatment market report are the U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, America accounts the largest market share because of increase in risk of gallbladder cancer to Native Americans. Other reasons for the largest market share are increase in research and development, high investments and increased sales of approved drugs. Asia-Pacific has the second largest market share especially in India due to increase in incidence of gallbladder cancer in women.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
The gallbladder cancer treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to gallbladder cancer treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the gallbladder cancer treatment market in the growth period.
Competitive Landscape and Gallbladder Cancer Treatment Market Share Analysis
The gallbladder cancer treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to gallbladder cancer treatment market.
The major players covered in the gallbladder cancer treatment market report are Cipla Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Pfizer Inc., F. Hoffmann-La Roche Ltd, Sanofi, OncoTherapy Science, Inc., Intuitive Surgical, Samarth Pharma Pvt. Ltd., GLS pharma ltd., Sun Pharmaceutical Industries Ltd. among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-